Pediatric CancerPALONCOPEDNCT07838168
Integration of Palliative Care in Pediatric Onco-hematology
An observational study of Pediatric Cancer and Palliative Care, run by Nantes University Hospital.
Trial summary
PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Pediatric Cancer, Palliative Care
- What is being tested?
- PALONCOPED semi-structured interview
- How many people
- 45 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2026to 1 May 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: We will focus on health professionals working in pediatric onco-hematology services and within the Pediatric Palliative Support Care Team. Participation in the study will be offered to professionals from targeted services by the research team directly in the services via both information by email, a poster in the break rooms and a project presentation meeting.
Who may be able to join
- Healthcare professional (doctor with a thesis that has validated his DES, qualified nurse or puériculturist, qualified childcare assistant or nursing assistant, qualified psychologist, qualified physiotherapist/occupational therapist) practicing in pediatric onco-hematology or within the Pediatric Palliative Support Care Team of three university hospital centers: Nantes, Angers, and Tours., with regular exercise for at least 3 months.
- Having been involved in supporting a child in a palliative situation in the last 9 months.
- Agreement of professionals to participate in the study, to record and transcribe interviews.
Who cannot join
None listed.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: PALONCOPED - Integration of Palliative Care in Pediatric Onco-hematology
PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between hematological malignancies and solid tumors. The study seeks to identify the obstacles and levers encountered by professionals in pediatric onco-haematology and pediatric palliative care resource teams. It will be conducted in the hospitals of Nantes, Angers and Tours, based on about 45 semi-structured individual interviews with healthcare professionals. The data will be analyzed according to a reflexive thematic analysis, supplemented if relevant by a lexical analysis. The project aims to identify ways to improve for organizational and relational improvement, to strengthen collaboration between teams, and to promote earlier, coordinated care pathways adapted to children and their families.
- Conditions
- Pediatric Cancer, Palliative Care
- Being tested
- PALONCOPED semi-structured interview
- Keywords
- pediatric Cancer, Palliative Care, Qualitative study
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PALONCOPED semi-structured interviewOther
Only one semi-structured interview will be conducted per participant. It is estimated that the average duration of interviews is 45 minutes (given for information purposes to allow participants to anticipate the time needed for this interview).
Individual interviews will be conducted by 1 researcher in Psychology. The researcher is trained in qualitative medicine and semi-structured interviews. He has extensive experience in this field.
| Study group | Role | What they receive |
|---|---|---|
| PALONCOPED Study population | The study will focus on healthcare professionals working in pediatric onco-haematology services and within the Pediatric Palliative Support Care Teams. Receives: Other: PALONCOPED semi-structured interview |
What is being measured
The primary outcome is the main question the study is designed to answer.
Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors)
Measured: Inclusion (Day 0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 May 2027 (estimated)
- Study completion1 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric CancerStudies of the same condition, open and under way.
- More trials run by Nantes University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 45 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nantes University Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Association CASSANDRA
- Responsible party
- Sponsor
- Investigators
- Estelle THEBAUD, Principal investigator, Nantes UHAdrien EVIN, Principal investigator, Nantes UH
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07838168
- Sponsor's protocol ID
- RC26_0226
- Acronym
- PALONCOPED
- Status last verified
- Sep 2026
- First submitted
- 18 Sep 2026
- Last updated
- 6 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PALONCOPED - Integration of Palliative Care in Pediatric Onco-hematology
- ClinicalTrials.gov ID
- NCT07838168
- Acronym / sponsor ID
- PALONCOPED / RC26_0226
- Conditions
- Pediatric Cancer, Palliative Care
- Keywords
- pediatric Cancer, Palliative Care, Qualitative study
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 45 participants (estimated)
- Lead sponsor
- Nantes University HospitalUniversity, hospital or other
- Collaborators
- Association CASSANDRA
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 1 May 2027 (estimated)
- Study completion
- 1 May 2027 (estimated)
- First posted
- 24 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
PALONCOPED is a multicentre, interregional, observational and qualitative study aiming to better understand the early integration of palliative care in children with cancer. This study compares the practices, representations and temporalities of integration according to the type of cancer, in particular between hematological malignancies and solid tumors. The study seeks to identify the obstacles and levers encountered by professionals in pediatric onco-haematology and pediatric palliative care resource teams. It will be conducted in the hospitals of Nantes, Angers and Tours, based on about 45 semi-structured individual interviews with healthcare professionals. The data will be analyzed according to a reflexive thematic analysis, supplemented if relevant by a lexical analysis. The project aims to identify ways to improve for organizational and relational improvement, to strengthen collaboration between teams, and to promote earlier, coordinated care pathways adapted to children and their families.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| PALONCOPED Study population | – | Other: PALONCOPED semi-structured interviewThe study will focus on healthcare professionals working in pediatric onco-haematology services and within the Pediatric Palliative Support Care Teams. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- We will focus on health professionals working in pediatric onco-hematology services and within the Pediatric Palliative Support Care Team. Participation in the study will be offered to professionals from targeted services by the research team directly in the services via both information by email, a poster in the break rooms and a project presentation meeting.
Key inclusion criteria (3 listed)
- Healthcare professional (doctor with a thesis that has validated his DES, qualified nurse or puériculturist, qualified childcare assistant or nursing assistant, qualified psychologist, qualified physiotherapist/occupational therapist) practicing in pediatric onco-hematology or within the Pediatric Palliative Support Care Team of three university hospital centers: Nantes, Angers, and Tours., with regular exercise for at least 3 months.
- Having been involved in supporting a child in a palliative situation in the last 9 months.
- Agreement of professionals to participate in the study, to record and transcribe interviews.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PALONCOPED semi-structured interviewOnly one semi-structured interview will be conducted per participant. It is estimated that the average duration of interviews is 45 minutes (given for information purposes to allow participants to anticipate the time needed for this interview). Individual interviews will be conducted by 1 researcher in Psychology. The researcher is trained in qualitative medicine and semi-structured interviews. He has extensive experience in this field. | Other | PALONCOPED Study population |
Primary outcome
Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors)
Time frame: Inclusion (Day 0)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Pediatric Cancer
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
RecruitingPhase 1/2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
RecruitingObservational study
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Pediatric Cancer
Active, not recruitingPhase 3
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
RecruitingObservational study
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
Knowledge, Attitudes, Practice
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Estelle THEBAUD principal investigator
Nantes UH
Adrien EVIN principal investigator
Nantes UH
Questions about this trial
What is this clinical trial studying?
An observational study of Pediatric Cancer and Palliative Care, run by Nantes University Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sponsor department (0253482835 ext. +33, bp-prom-regl@chu-nantes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identify the barriers and levers for the early integration of palliative care into pediatric oncology-hematology care, depending on the type of pathology (malignant blood diseases versus so-lide tumors) (time frame: Inclusion (Day 0)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.